Lan Thi Phi

Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics

A pan-cancer study of selenoprotein genes as promising targets for cancer therapy

Lipid nanoparticles for mRNA delivery

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity

Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications

PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment

Interferons α and β in cancer: therapeutic opportunities from new insights

Nanomedicine-Based Approaches for mRNA Delivery

Production of endothelial progenitor cells from skin fibroblasts by direct reprogramming for clinical usages

Interferon-induced transmembrane protein 1 (IFITM1) is required for the progression of colorectal cancer

Interferon‐induced transmembrane protein 1‐mediated EGFR/SOX2 signaling axis is essential for progression of non‐small cell lung cancer

Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment